These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 38107643)
41. Identifying the mental health burden in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients in Switzerland: A pilot study. König RS; Paris DH; Sollberger M; Tschopp R Heliyon; 2024 Mar; 10(5):e27031. PubMed ID: 38434357 [TBL] [Abstract][Full Text] [Related]
42. The persistence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after SARS-CoV-2 infection: A systematic review and meta-analysis. Dehlia A; Guthridge MA J Infect; 2024 Sep; 89(6):106297. PubMed ID: 39353473 [TBL] [Abstract][Full Text] [Related]
43. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520 [TBL] [Abstract][Full Text] [Related]
44. Virtual reality education on myalgic encephalomyelitis for medical students and healthcare professionals: a pilot study. Anderson T; Duffy G; Corry D BMC Med Educ; 2024 Sep; 24(1):1018. PubMed ID: 39289650 [TBL] [Abstract][Full Text] [Related]
45. Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases. McGregor NR; Armstrong CW; Lewis DP; Gooley PR Diagnostics (Basel); 2019 Jul; 9(3):. PubMed ID: 31277442 [TBL] [Abstract][Full Text] [Related]
46. Improvement of Long COVID symptoms over one year. Oliveira CR; Jason LA; Unutmaz D; Bateman L; Vernon SD Front Med (Lausanne); 2022; 9():1065620. PubMed ID: 36698810 [TBL] [Abstract][Full Text] [Related]
47. Experiences of general practitioner continuity among women with chronic fatigue syndrome/myalgic encephalomyelitis: a cross-sectional study. Hansen AH; Lian OS BMC Health Serv Res; 2016 Nov; 16(1):650. PubMed ID: 27842587 [TBL] [Abstract][Full Text] [Related]
48. Examining Well-Being and Cognitive Function in People with Long COVID and ME/CFS, and Age-Matched Healthy Controls: A Case-Case-Control Study. Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Berry ECJ; Sculthorpe NF Am J Med; 2024 May; ():. PubMed ID: 38750713 [TBL] [Abstract][Full Text] [Related]
49. Three Cases of Severe ME/CFS in Adults. Williams LR; Isaacson-Barash C Healthcare (Basel); 2021 Feb; 9(2):. PubMed ID: 33669438 [TBL] [Abstract][Full Text] [Related]
50. The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Grande T; Grande B; Gerner P; Hammer S; Stingl M; Vink M; Hughes BM Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109676 [TBL] [Abstract][Full Text] [Related]
51. Modulatory effects of cognitive exertion on regional functional connectivity of the salience network in women with ME/CFS: A pilot study. Manca R; Khan K; Mitolo M; De Marco M; Grieveson L; Varley R; Wilkinson ID; Venneri A J Neurol Sci; 2021 Mar; 422():117326. PubMed ID: 33556867 [TBL] [Abstract][Full Text] [Related]
52. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Ghali A; Lacout C; Ghali M; Gury A; Beucher AB; Lozac'h P; Lavigne C; Urbanski G Sci Rep; 2019 Dec; 9(1):18817. PubMed ID: 31827223 [TBL] [Abstract][Full Text] [Related]
53. Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention Study. Sørland K; Sandvik MK; Rekeland IG; Ribu L; Småstuen MC; Mella O; Fluge Ø Front Med (Lausanne); 2021; 8():642710. PubMed ID: 33829023 [No Abstract] [Full Text] [Related]
54. Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Rohrhofer J; Hauser L; Lettenmaier L; Lutz L; Koidl L; Gentile SA; Ret D; Stingl M; Untersmayr E J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202282 [TBL] [Abstract][Full Text] [Related]
55. Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS. Kim L; Kedor C; Buttgereit F; Heidecke H; Schaumburg D; Scheibenbogen C J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568396 [TBL] [Abstract][Full Text] [Related]
58. The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome. Thomas N; Gurvich C; Huang K; Gooley PR; Armstrong CW Front Neuroendocrinol; 2022 Jul; 66():100995. PubMed ID: 35421511 [TBL] [Abstract][Full Text] [Related]
59. 'We have no services for you… so you have to make the best out of it': A qualitative study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients' dissatisfaction with healthcare services. Melby L; Nair RD Health Expect; 2024 Feb; 27(1):e13900. PubMed ID: 37905602 [TBL] [Abstract][Full Text] [Related]
60. One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus. Pricoco R; Meidel P; Hofberger T; Zietemann H; Mueller Y; Wiehler K; Michel K; Paulick J; Leone A; Haegele M; Mayer-Huber S; Gerrer K; Mittelstrass K; Scheibenbogen C; Renz-Polster H; Mihatsch L; Behrends U Front Pediatr; 2023; 11():1266738. PubMed ID: 38304441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]